Verana Health
Real Evidence
Real Insights
95M+
25K+
17
of top
200+
34+
Disease Areas
200+
YouTube
Video Player
Real-World Evidence in Action
The Industry Leader in Real-World Evidence Solutions
Revolutionizing patient care and clinical research though real-world data
RWD Curation Platform
Powered by our proprietary platform, we combine deep expertise, secure advanced technology, and direct access to exclusive data sources to provide actionable quality insights.
[Learn More](/content/about-verana-health/ "Click Here"/index.html)
Exclusive Data Network
Through exclusive partnerships with leading medical societies, preferred oncology networks, and proprietary registries, Verana Health offers an unsurpassed volume of essential research data.
[Learn More](/content/societies/ "Click Here"/index.html)
Solutions
From protocol to commercialization, Verana's clinical research solutions leverage quality RWD and technology to transform clinical research and deliver effective and efficient clinical trials.
[Learn More](/content/clinical-research-solutions/ "Click Here"/index.html)
Disease-Specific Datasets
Verana Health creates high-quality datasets at scale offering unmatched, research-ready, disease-specific datasets across: Oncology, Ophthalmology, Neurology, and Urology.
[Learn More](/content/products/ "Click Here"/index.html)
Who We Help
Medical Affairs & HEOR
Post-Marketing Requirements (PMRs): Efficiently fulfill safety and efficacy mandates required by regulatory bodies post-approval without the crushing cost of a traditional prospective registry.
Comparative Effectiveness & Burden of Illness: Provide HEOR teams with granular outcome tracking to prove your drug outperforms the standard of care.
Journal Publications: Turn the world's largest specialty datasets into abstract submissions and peer-reviewed publications that establish market authority.
Clinical Development
Protocol Feasibility Modeling: Stop guessing if your Inclusion/Exclusion criteria are too restrictive. Stress test your protocols.
Precision Site Identification: Pinpoint clinical sites and specific investigators who currently treat patients matching your study requirements.
External Control Arms (ECAs): For rare diseases, oncology or single-arm trials, we leverage our deeply curated historical cohorts to build regulatory-grade synthetic control arms that satisfy FDA/EMA requirements.
Clinicians
MIPS Submissions: Confidently navigate your Merit-based Incentive Payment System (MIPS) requirements with our MIPS Advisory Services.
Verana Research Network: An ever-expanding clinical trials site network of active trials locations, affiliated with therapeutic-specific medical registries.
Ophthalmology Solutions: Provides clinicians with the data needed to monitor, gauge, and optimize daily operations and help practices enhance the quality of their patient care by benchmarking quality measure performance and identifying specific and actionable opportunities for improvement.
Commercial Strategy
Market Intelligence: Go beyond standard line-of-therapy claims tracking. Understand exactly when and where your drug is being utilized in first, second, or third-line settings.
Adherence and Switch Insights: Track adherence and reasons for physicians switching a patient off a competitor's drug (e.g., mild side effects, cost barriers, slow progression) so your sales force can refine their messaging.
Hyper-Targeted Field Force Deployment: Identify geographic pockets or specific clinician types showing a high volume of patients experiencing treatment failure on existing therapies, representing immediate expansion opportunities.
Trusted by Global Companies
Redefining Research and Life Sciences Outcomes
See how real-world evidence is generated, shared, and applied.
Case Studies
Underutilization of Genomic Sequencing in Oncology
RWD Study Reveals Benefits of Gocovri for Parkinson's Disease Patients
Uncontrolled nAMD: Real-World Disease Burden in the US and UK
Customer Stories
Syneos Health Recruits High-Performing Sites to Beat Forecasted Trial Start Date
Largest FDA-Funded IOL Study of Pediatric Patients Highlights Significance of Real-World Data
Sight Sciences Uses RWE to Refine Patient Segmentation and Reverse a Medicare Ruling for OMNI